Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
B 17.48 -3.69% -0.67
NURO closed down 3.69 percent on Tuesday, July 27, 2021, on 57 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NURO trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Parabolic Rise Strength -3.69%
Upper Bollinger Band Walk Strength -3.69%
Multiple of Ten Bearish Other -3.69%
Wide Bands Range Expansion -3.69%
Older End-of-Day Signals for NURO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 4 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Down 5% about 7 hours ago
Down 3% about 7 hours ago
Down 2 % about 8 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroMetrix, Inc. Description

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Pain Clinics Diabetes Neuroscience Managed Care Pain Management Nerve Primary Care Neuromodulation Neurotechnology Nervous System Neurophysiology Acute Pain Endocrinology Perception Spinal Cord Podiatry Diabetic Peripheral Neuropathy Peripheral Neuropathy Sensus Spinal Cord Disorders Carpal Tunnel Carpal Tunnel Syndrome Electrodiagnosis Physical Medicine And Rehabilitation Spinal Stenosis Transcutaneous Electrical Nerve Stimulation

Is NURO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.75
52 Week Low 1.39
Average Volume 9,247,745
200-Day Moving Average 3.53
50-Day Moving Average 5.15
20-Day Moving Average 7.97
10-Day Moving Average 12.52
Average True Range 4.08
ADX 38.95
+DI 45.86
-DI 8.73
Chandelier Exit (Long, 3 ATRs) 26.51
Chandelier Exit (Short, 3 ATRs) 15.26
Upper Bollinger Bands 22.86
Lower Bollinger Band -6.93
Percent B (%b) 0.82
BandWidth 373.92
MACD Line 4.12
MACD Signal Line 2.45
MACD Histogram 1.6732
Fundamentals Value
Market Cap 66.16 Million
Num Shares 3.78 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -44.25
Price-to-Sales 0.66
Price-to-Book 1.44
PEG Ratio -0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.84
Resistance 3 (R3) 23.02 21.43 21.94
Resistance 2 (R2) 21.43 20.06 21.33 21.64
Resistance 1 (R1) 19.45 19.22 18.66 19.27 21.35
Pivot Point 17.86 17.86 17.46 17.76 17.86
Support 1 (S1) 15.88 16.49 15.09 15.70 13.61
Support 2 (S2) 14.29 15.65 14.19 13.32
Support 3 (S3) 12.31 14.29 13.02
Support 4 (S4) 12.13